Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 11 (5) , 485-490
- https://doi.org/10.1097/00001721-200007000-00011
Abstract
The circulating levels of angiotensin I-converting enzyme (ACE) are linked with a 287-base pair insertion/deletion (I/D) polymorphism at intron 16 of the ACE gene. Thus, the homozygous deletion (D/D genotype) could cause chronic vasoconstriction, arterial hypertension and, possibly, coronary artery disease. Also, the increase in plasminogen activator inhibitor-1 level and impaired fibrinolysis were related with the D/D genotype. The D allele has been recently associated with venous thrombosis among African–American men as well as among patients that underwent elective total hip replacement. We assess the risk of venous thromboembolism (VTE) linked with each genotype of the I/D ACE gene polymorphism in a Caucasian population by means of a case-control study. We genotyped the ACE gene in a series of 148 patients aged 45.0 ± 16.0 years (range, 11–80 years), objectively diagnosed in our centre of deep-vein thrombosis or pulmonary embolism, and in 240 thrombosis-free subjects (25–75 years) from the same geographic area. The observed difference in D allele frequencies between patients (0.56) and controls (0.62) was nonsignificant overall; however, statistical significance (P= 0.05) was found by considering the recessive hypothesis (D/D versus I/D + I/I) [odds ratio (OR) = 0.64, 95% confidence interval (CI95) = 0.42–0.99]. The OR was 0.88 (CI95 = 0.51–1.53;P= 0.65) for the dominant hypothesis (D/D + I/D versus I/I genotypes). The relative risk for the D allele was close to 1 for the dominant hypothesis, both considering gender and recurrent tendency; however, it was protective in men regarding the recessive hypothesis (OR = 0.53, CI95 = 0.29–0.97,P= 0.04). The I/D ACE allele distribution was similar among the 46 thrombophilic patients (antithrombin, protein C or protein S deficiencies, factor V R506Q, factor II G20210A or lupus anticoagulant). In conclusion, among (Spanish) Caucasians, this study does not support the hypothesis that the deletion allele (D) of the ACE gene could be a significant risk factor for VTE, being protective in men.Keywords
This publication has 24 references indexed in Scilit:
- Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertensionPublished by Elsevier ,2004
- Evidence for Association and Genetic Linkage of the Angiotensin-Converting Enzyme Locus With Hypertension and Blood Pressure in Men but Not Women in the Framingham Heart StudyCirculation, 1998
- Association of angiotensin converting enzyme activity and arterial blood pressure in a population-based sampleJournal Of Hypertension, 1996
- Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction but Not With Development of Coronary StenosisCirculation, 1995
- DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.Circulation, 1994
- Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular HypertrophyNew England Journal of Medicine, 1994
- Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring StudyJournal Of Hypertension, 1993
- Association Analysis of a Polymorphism of the Angiotensin Converting Enzyme Gene with Essential Hypertension in the Japanese PopulationBiochemical and Biophysical Research Communications, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990